跳至主要内容
临床试验/CTRI/2020/10/028608
CTRI/2020/10/028608尚未招募不适用

Assessment of Growth of primary cells form solid tumors on Axtex-4D, the Ex vivo tissueoid generator platform

Premas Biotech Pvt Ltd1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年10月26日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,000
试验地点
1
主要终点
Development of tissueoid generation platform, AXTEX-4D, that shall aid in growing tumor tissues ex vivo

研究概览

简要总结

The proposed research study involving development of tissueoid generationplatform (Axtex-4D) that shall aid in growing tumor tissues ex vivo, mimicsthe in vivo tumor properties for clinically relevant studies and treatmentprotocol analysis

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Absence of long term/chronic disease will be preferred
  • Sample cohort should be an heterogenous mixture of individuals from different demographic regions of the country with difference in ethnic and racial origin 3.Treatment naïve individuals.

排除标准

  • 1.Tissues from terminally ill patient.
  • 2.Not require treatment-experienced or prior-treatment-failed “salvage†participants tumor.
  • 3.Size <100 mg.

结局指标

主要结局

Development of tissueoid generation platform, AXTEX-4D, that shall aid in growing tumor tissues ex vivo

时间窗: Not Applicable

次要结局

  • Not Applicable(Not Applicable)

研究者

申办方类型
Other [Technology Platform Development]

研究点 (1)

Loading locations...

相似试验